Publications by authors named "Peter Uebel"

Claim this Profile
A
Assessment of Patient-Reported Outcome Measures in Patients Undergoing Bowel Preparation With Mannitol for Colonoscopy: The SATISFACTION Study.
Gian Eugenio Tontini, Cristiano Spada, Peter Uebel, Renato Cannizzaro, Giorgio Ciprandi

JGH Open· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mannitol for bowel preparation: Efficacy and safety results from the SATISFACTION randomised clinical trial.
Maurizio Vecchi, Gian Eugenio Tontini, Giancarla Fiori, Paolo Bocus, Marino Carnovali, Peter Uebel

Dig Liver Dis· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modified-Release Phosphatidylcholine (LT-02) for Ulcerative Colitis: Two Double-Blind, Randomized, Placebo-Controlled Trials.
Axel Dignass, Wolfgang Stremmel, Marek Horyński, Oleksandr Poyda, Peter Armerding, Peter Uebel

Clin Gastroenterol Hepatol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors influencing the presence of potentially explosive gases during colonoscopy: Results of the SATISFACTION study.
Marino Carnovali, Cristiano Spada, Peter Uebel, Paolo Bocus, Renato Cannizzaro

Clin Transl Sci· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral mannitol for bowel preparation: a dose-finding phase II study.
Cristiano Spada, Giancarla Fiori, Peter Uebel, Gian Eugenio Tontini, Paola Cesaro

Eur J Clin Pharmacol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study.
Silvio Danese, Janusz Rudziński, Wolfgang Brandt, Jean-Louis Dupas, Laurent Peyrin-Biroulet, Peter Uebel

Gut· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First multicenter study of modified release phosphatidylcholine "LT-02" in ulcerative colitis: a randomized, placebo-controlled trial in mesalazine-refractory courses.
Max Karner, Andreas Kocjan, Juergen Stein, Stefan Schreiber, Georg von Boyen, Peter Uebel

Am J Gastroenterol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis